跳至主要内容
临床试验/DRKS00025491
DRKS00025491尚未招募未知

A Randomized, Experimental Evaluation Study of the Patient-Related, Medical, and Health Care Benefits of the Digital Therapy Companion TINO DTB (Therapy In Oncology Digital Therapy Companion). - TINO-DTB DiGA

DTB Gesellschaft für digitale Therapiebegleitung mbH0 个研究点目标入组 320 人开始时间: 2021年6月21日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
320

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Any of the following oncologic indications: Malignant neoplasm of the mammary gland (BC; ICD-10 code: C50.-), Malignant neoplasm of the bronchi and lungs (LC; ICD-10 code: C34.-), Multiple myeloma (MM; ICD-10 code: C90. 0); restart of oral systemic oncology therapy, minimum age: 18 years, signed Informed Consent (IC) at baseline, physician assessment of whether the patient is able to use the Tino DTB application.

排除标准

  • No oral cancer therapy. Under age.

研究者

发起方
DTB Gesellschaft für digitale Therapiebegleitung mbH

相似试验